Competition & Peer Data API & CSV Delivery

Eargo Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Eargo Inc (EAR) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2023
Competitors Tracked
1
Publicly traded peers
Peer Group Market Share
61.06 %
vs 35.33 % a year ago
Revenue Growth Y/Y
-7.27 %
Peers: -67.69 %
Net Margin
-236.30 %
Peers: -125.29 %

Key Findings: Eargo Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 40M vs 28M combined for tracked competitors (58.5% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-26.1% annualized vs trailing 12 months), vs decelerating (-33.5%) for its tracked peer group.
  • Growth: Eargo Inc generated -7.3% revenue growth year over year in Q3 2023, vs -67.7% for its tracked competitors combined.
  • Profitability: Its -236.3% net margin compares with -125.3% for the peer group.
  • Peer revenue share: Eargo Inc accounted for 61.1% of combined revenue among its tracked peer group, up from 35.3% a year earlier.
  • Peer differentiation: Revenue per employee of $0.27M compares with $0.16M for the peer group (1.7x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

EAR Sales vs. its Competitors, Q3 2023

Eargo Inc reported revenue contraction of 7.27 % year on year in Q3 2023, above its competitors' combined revenue change of -67.69 %.

With a net margin of -236.30 %, Eargo Inc reported lower profitability than its competitors (-125.29 %).

Eargo Inc generated 61.06 % of the combined sales of its peer group, up from 35.33 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/EAR/competitors
https://api.csimarket.com/api/v1/companies/EAR/relationships
https://api.csimarket.com/api/v1/companies/EAR/similar
Programmatic access for models, analytics, and integration workflows.

Eargo Inc vs. its Competitors, Q3 2023

Revenue growth, year on year

Eargo Inc -7.3 %
Competitors combined -67.7 %

Net margin

Eargo Inc -236.3 %
Competitors combined -125.3 %

Revenue run-rate vs trailing 12 months

Eargo Inc -26.1 %
Competitors combined -33.5 %

TTM net margin

Eargo Inc -272.5 %
Competitors combined +118.1 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Eargo Inc and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Eargo Inc $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Eargo Inc's competitor groups requires a Commercial License.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs -7.3% for Eargo Inc. Eargo Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.

Eargo Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Eargo Inc No - - No
Competitors combined (1) 100% 0% 0% 0%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2023

61.1%market share
  • Eargo Inc61.1%
  • Competitors combined38.9%

Share of combined quarterly revenue of Eargo Inc and its 1 tracked competitors.

See Eargo Inc's full market share breakdown »

EAR Stock Performance relative to its Competitors

EAR Competitors (weighted) Percent change over the selected range

Eargo Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
Competitors Combined
(0 of 1)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Eargo Inc - -
Competitors combined (1) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Eargo Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 1847 Holdings Llc 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Eargo Inc's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Publicly Traded Peers of Eargo Inc

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Eargo Inc 53.34 39.69 -108.17 145
1847 Holdings Llc 4.62 28.12 33.20 178
SUBTOTAL 57.96 67.81 -74.97 323

Sources: Eargo Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Eargo Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Eargo Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
1847 Holdings Llc Kyles 93.13 % Kyles 93.13 % Wolo 6.87 %

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Eargo Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Eargo Inc 53 273,752 -746,021
1847 Holdings Llc 5 157,966 186,523
PEERS TOTAL 5 157,966 186,523

Eargo Inc's Profitability & Cost Structure

Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Medical Equipment & Supplies industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (288 companies).
Metric Company Industry Difference
Gross Margin 43.45 % 53.35 % (avg) -9.9 pp
Operating Margin -227.82 % industry median -208.9 pp
EBITDA Margin -249.76 % -6.82 % (avg) -242.9 pp
Capital Intensity (Capex / Revenue) 1.38 % 5.43 % (avg) -4.0 pp

Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.

Eargo Inc's Valuation vs Competitive Position

Valuation multiples vs the Medical Equipment & Supplies industry average (288 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E - 34.6x -
EV / EBITDA - 19.7x -
P/B 0.7x 4.7x -4.0x
Return on Equity -150.17 % industry aggregate -153.49 %
Return on Invested Capital -59.92 % -2.32 % (avg) -57.60 %

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Eargo Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.
Metric 202020212022
Revenue Growth --167.31 %-
Operating Margin -431.55 %-300.04 %
Return on Invested Capital --70.71 %-165.53 %
P/E ---

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Eargo Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Barriers to Entry Lower than typical for the industry Capital intensity (capex / revenue) of 1.38 % vs industry average 5.43 % (see Profitability & Cost Structure above)
Supplier Power Not covered on this page See Eargo Inc's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Eargo Inc's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Eargo Inc's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective
Harvest
Harvest / Divest Eargo Inc

Eargo Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Eargo Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

No rule matched.

Weaknesses

  • Operating margin 208.9 points below the industry median.
  • Return on equity 153.5 points below the industry aggregate.
  • Latest-quarter revenue run-rate is decelerating (-26.1% annualized vs trailing 12 months).

Opportunities

No rule matched.

Threats

  • Tracked peer group's revenue run-rate is broadly decelerating (-33.5% annualized).

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Eargo Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Eargo Inc 3.26 3.88 - 0.39
1847 Holdings Llc 0.01 0.35 - 0.83

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Eargo Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Eargo Inc Q3 2023-7.3 %-3.9 %--
1847 Holdings LlcQ2 2026-12.5 %+34.1 %--
PEERS TOTAL-8.2 %+1.1 %--

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Eargo Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Eargo Inc Q3 2023-50.1 %-50.0 %-96.0 %-86.1 %
1847 Holdings LlcQ2 2026-21.2 %+13.5 %--

Eargo Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Eargo Inc ---27.364.58
1847 Holdings Llc98.04%--11.8755.68

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Eargo Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Eargo Inc -1.34--1.18
1847 Holdings Llc1.180.16-0.92-
PEERS AVERAGE-0.85-10.78

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.